TBR-652
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TBR-652, covering 2013-07-10 to 2013-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients [Phase 1, Phase 2]